OAC
ALT icon

OMERS Administration Corp’s Altimmune ALT Stock Holding History

OMERS Administration Corp’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-104,600
Closed -$1.06M – 1038
2024
Q1 		$1.06M Buy
+104,600
New +$1.06M 0.01% 155

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OMERS Administration Corp's ALT Position: Q2 2024 in Review

OMERS Administration Corp sold out of Altimmune (ALT) in Q2 2024, closing a stake of 104,600 shares — an estimated $1.06M sold.

OMERS Administration Corp first reported a position in ALT in Q1 2024 and held it in 1 quarter. The position peaked at $1.06M in Q1 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q2 2024.

  • OMERS Administration Corp reported no remaining Altimmune position as of Q2 2024 after selling out during the quarter.
  • OMERS Administration Corp sold 104,600 Altimmune shares in Q2 2024, an estimated $1.06M.
  • OMERS Administration Corp first reported a position in Altimmune in Q1 2024 and held it in 1 quarter.
  • OMERS Administration Corp's Altimmune position peaked at $1.06M in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q2 2024.

Based on OMERS Administration Corp's 13F filing for Q2 2024, filed 13 Aug 2024.